Wuzhou Medical: Abnormal fluctuations in stock trading, with the price-to-earnings ratio significantly higher than the industry average.

Wuzhou Medical announced that the company's stock experienced an abnormal fluctuation, with the cumulative price deviation reaching 30.22% over two consecutive trading days on August 7 and August 10, 2026. As of August 10, the company's dynamic and static price-to-earnings ratios were 194.03 times and 330.73 times, respectively, significantly higher than the industry average. The company's operations are normal, and aside from the disclosed acquisition plan, there are no undisclosed matters that should be revealed. Investors are reminded to pay attention to acquisition risks, differences in price-to-earnings ratios, and the disclosure of the semi-annual report, and to invest rationally.